UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Infosys
INFY
|
+$767M |
| 2 |
Amazon
AMZN
|
+$288M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$287M |
| 4 |
NVIDIA
NVDA
|
+$259M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$249M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$347M |
| 2 |
TWTR
Twitter, Inc.
TWTR
|
+$316M |
| 3 |
Citigroup
C
|
+$269M |
| 4 |
Charter Communications
CHTR
|
+$229M |
| 5 |
NetEase
NTES
|
+$211M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.35% |
| 2 | Consumer Discretionary | 13.14% |
| 3 | Financials | 12.19% |
| 4 | Healthcare | 12.04% |
| 5 | Communication Services | 9.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
751
Reliance Steel & Aluminium
RS
$21.6B
| $26.1M | 0.01% |
171,171
-50,876
| -23% | -$6.84M |
|
|
XLRN
752
DELISTED
Acceleron Pharma
XLRN
| $25.9M | 0.01% |
190,754
-47,995
| -20% | -$6.2M |
|
753
Medpace
MEDP
$16.5B
| $25.8M | 0.01% |
157,399
-428
| -0.3% | -$65.5K |
|
754
Kohl's
KSS
$2.19B
| $25.7M | 0.01% |
431,204
-16,239
| -4% | -$834K |
|
755
Flex
FLEX
$44.8B
| $25.7M | 0.01% |
1,861,435
-35,912
| -2% | -$495K |
|
756
GDS Holdings
GDS
$6.41B
| $25.7M | 0.01% |
316,464
+2,185
| +0.7% | +$218K |
|
757
Apollo Global Management
APO
$73.4B
| $25.6M | 0.01% |
545,481
-506,472
| -48% | -$24.6M |
|
758
Bloomin' Brands
BLMN
$938M
| $25.4M | 0.01% |
939,990
+845,038
| +890% | +$20.5M |
|
759
iShares MSCI Saudi Arabia ETF
KSA
$621M
| $25.4M | 0.01% |
707,300
-75,800
| -10% | -$2.48M |
|
|
SEE
760
DELISTED
Sealed Air
SEE
| $25.3M | 0.01% |
552,519
+51,871
| +10% | +$2.32M |
|
761
Gentex
GNTX
$5.07B
| $25.2M | 0.01% |
705,998
-216,284
| -23% | -$7.68M |
|
762
Evercore
EVR
$11.8B
| $25.1M | 0.01% |
190,546
+50,838
| +36% | +$6.21M |
|
|
BPMC
763
DELISTED
Blueprint Medicines
BPMC
| $25.1M | 0.01% |
258,165
-79,837
| -24% | -$7.97M |
|
764
Zillow
ZG
$7.63B
| $25.1M | 0.01% |
190,688
+21,261
| +13% | +$3.28M |
|
765
Fate Therapeutics
FATE
$326M
| $24.7M | 0.01% |
299,593
-110,832
| -27% | -$10.6M |
|
766
Chemed
CHE
$7.22B
| $24.6M | 0.01% |
53,607
+492
| +0.9% | +$241K |
|
|
LSXMK
767
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
| $24.2M | 0.01% |
709,006
+11,449
| +2% | +$384K |
|
|
DOC
768
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $24.2M | 0.01% |
1,368,562
+210,086
| +18% | +$3.73M |
|
769
Autohome
ATHM
$2.62B
| $24.1M | 0.01% |
257,859
-19,825
| -7% | -$2.2M |
|
|
HR
770
DELISTED
Healthcare Realty Trust Incorporated
HR
| $24M | 0.01% |
792,506
-2,267
| -0.3% | -$68.2K |
|
771
Caesars Entertainment
CZR
$6.14B
| $23.9M | 0.01% |
273,610
+105,238
| +63% | +$8.83M |
|
772
Diamondback Energy
FANG
$52.7B
| $23.9M | 0.01% |
324,940
+32,290
| +11% | +$2.21M |
|
|
AZEK
773
DELISTED
The AZEK Co
AZEK
| $23.9M | 0.01% |
567,759
+32,492
| +6% | +$1.39M |
|
774
FirstService
FSV
$6.32B
| $23.6M | 0.01% |
159,304
+29,988
| +23% | +$4.37M |
|
775
Charles River Laboratories
CRL
$12.8B
| $23.5M | 0.01% |
81,217
-10,479
| -11% | -$2.91M |
|
Similar funds
UBS AM's Q1 2021 Portfolio in Review
As of Q1 2021, UBS AM held 2,645 positions worth $226B, up 6% from $213B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Trading was light in Q1 2021: portfolio turnover was 4.9%. UBS AM opened 86 new positions and exited 44, leaving the 2,645-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Financials.
- UBS AM's largest Q1 2021 buy was Seagen Inc. Common Stock: 966,114 shares worth $134M.
- UBS AM added most to Infosys in Q1 2021, an estimated $767M increase.
- UBS AM's biggest Q1 2021 reduction was Alibaba, cutting an estimated $347M.
- UBS AM fully exited Lumen in Q1 2021, selling an estimated $45.5M.
- UBS AM's ten largest holdings make up 22% of its $226B portfolio in Q1 2021.
- UBS AM opened 86 new positions and closed 44 in Q1 2021.
- UBS AM's portfolio value rose 6% quarter-over-quarter to $226B.
Based on UBS AM's 13F filing for Q1 2021, filed 14 May 2021.